Showing results (2551-2560 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|July 28, 2011
Are beta2-agonists responsible for increased mortality in heart failure?Margaret Bermingham, Eleanor O'Callaghan, Ian Dawkins, et al.
European Journal of Heart Failure|July 28, 2011
The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristicsRichard Lowrie, Frances S Mair, Nicola Greenlaw, et al.
European Journal of Heart Failure|December 7, 2010
Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO studyCristina Giglioli, Daniele Landi, Emanuele Cecchi, et al.
European Journal of Heart Failure|April 13, 2011
Systematic review of pregnancy in women with inherited cardiomyopathiesSébastien P J Krul, Jasper J van der Smagt, Maarten P van den Berg, et al.
European Journal of Heart Failure|August 3, 2011
Mitral annular plane systolic excursion on exercise: a simple diagnostic tool for heart failure with preserved ejection fractionFrauke W G Wenzelburger, Yu Ting Tan, Ferrah J Choudhary, et al.
European Journal of Heart Failure|August 4, 2011
Multicentre study using strain delay index for predicting response to cardiac resynchronization therapy (MUSIC study)Pascal Lim, Erwan Donal, Stéphane Lafitte, et al.
European Journal of Heart Failure|August 4, 2011
Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational studyAmit R Patel, Michael R Klein, Sonal Chandra, et al.
European Journal of Heart Failure|June 29, 2011
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESCRalph Knöll, Guido Iaccarino, Guido Tarone, et al.
European Journal of Heart Failure|April 7, 2011
Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment studyBertram Pitt, Roberto Latini, Aldo P Maggioni, et al.
European Journal of Heart Failure|December 20, 2011
Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failureAntoni Bayes-Genis, Marta de Antonio, Amparo Galán, et al.
Pageof 398